Search

The Zebrafish has gained increased popularity as an aquatic model species in various research fields, and its widespread use has led to numerous mutant strains and transgenic lines. This creates the need to store these important genetic materials as frozen gametes. Sperm cryopreservation in zebrafish has been shown to yield very low post-thaw survival and many protocols suffer from great variability and poor reproducibility. The present study was intended to develop a freezing protocol that can be reliably used to cryopreserve zebrafish sperm with high post-thaw survival. In particular, our study focused on cooling protocol optimization with the aid of cryomicroscopy. Specifically, sperm suspended in 8% DMSO or 4% MeOH were first incubated with live/dead fluorescent dyes (SYBR14/PI) and then cooled at various rates from 4°C to different intermediate stopping temperatures such as −10, −20, −30 and −80°C before rewarming to 35°C at the rate of 100°C/min. %PI-positive (dead) cells were monitored throughout the cooling process and this screening yielded an optimal rate of 25°C/min for this initial phase of freezing. We then tested the optimal cooling rate for the second phase of freezing from various intermediate stopping temperatures to −80°C before plunging into liquid nitrogen. Our finding yielded an optimal intermediate stopping temperature of −30°C and an optimal rate of 5°C/min for this second phase of freezing. When we further applied this two-step cooling protocol to the conventional controlled-rate freezer, the average post-thaw motility measured by CASA was 46.8±6.40% across 11 males, indicating high post-thaw survival and consistent results among different individuals. Our study indicates that cryomiscroscopy is a powerful tool to devise the optimal cooling conditions for species with sperm that are very sensitive to cryodamage. [ABSTRACT FROM AUTHOR]

Abstract: The present study employed cryomicroscopy to derive an optimal sperm freezing protocol for guppy (Poecilia reticulata) sperm. Evaluation criteria during the freezing–thawing process were assessed for nucleation temperature (Tn), temperature when more than 50% of sperm display bending mid-piece (Tb), temperature when more than 80% of sperm stop moving (Tm), thawing temperature (Tt), and post-thaw motility. We compared four different cryoprotectants: 5% N-dimethyl formamide (DMF), 6% methanol (MEOH), 10% dimethyl sulfoxide (DMSO), and 14% glycerol, as well as glycerol at different concentrations of 7–50%; cooling and rewarming rates ranged from 5 to 100°C/min. The protocol that yielded the highest post-thaw motility was samples suspended in 14% glycerol, cooled at 25°C/min, and thawed at 100°C/min, which was in complete agreement with our previous findings derived from a controlled-rate freezer. In addition, Tb and Tm were found to be negatively correlated with post-thaw motility, suggesting their possible role in predicting freezing success. The present study for the first time demonstrated the usefulness of cryomicroscopy in deriving an optimal sperm freezing protocol for aquatic species. [ABSTRACT FROM AUTHOR]

Abstract: Pain caused by liver tumors can be alleviated by cryoablation, but little is known about the analgesic effects and duration of pain alleviation. We retrospectively reviewed the changes in the severity of pain before and after percutaneous cryoablation of hepatic tumors. Each patient enrolled in this study had a single hepatic tumor; patients with large tumors (major diameter, ⩾5cm) underwent transarterial chemoembolization (TACE) first and then cryoablation. Severe abdominal pain that was not controlled with long-lasting oral analgesics was treated with opioid injections. In all 73 study patients, severe abdominal pain was gradually eased 5days after cryosurgery, completely disappeared after 15days and did not recur for more than 8weeks. There were no differences in analgesic effects between patients with hepatocellular carcinomas and those with liver metastasis (P >0.05). The patients were divided into four groups depending on their pain outcomes: (i) immediate relief (n =6), severe abdominalgia was no longer present after cryosurgery; (ii) delayed relief (n =11), severe abdominalgia disappeared gradually within 15days after the cryosurgery; (iii) always pain-free (n =39), severe abdominalgia was not present before or after treatment; and (iv) new pain (n =17), abdominalgia developed after treatment and disappeared within 15days. In summary, percutaneous cryoablation of hepatic tumors caused short-term pain in some patients, but this pain disappeared within 15days. Moreover, the pain-relieving effect of this treatment was sustained for at least 8weeks, without severe side effects. [Copyright &y& Elsevier]